Beef Quality Assurance certification gives producers tools to provide the safest and highest quality beef to consumers.
For the third time, Boehringer Ingelheim Vetmedica, Inc. (BIVI) is supporting the checkoff-funded Beef Quality Assurance (BQA) program by sponsoring all online certifications this fall for producers who enroll from September 1-October 31. Boehringer Ingelheim Vetmedica, Inc. will pick up the $25-$50 certification fee for beef or dairy producers who are interested in becoming certified or recertified during this period. Visit www.BIVI-BQA.com
The BQA program is important to the cattle industry as it gives producers a set of best practices for producing a safe and high quality beef product. And for dairy producers, this offering is also beneficial as a large percentage of dairy calves and market cows make their way into the food chain.
The BQA certification modules are customized to fit the specific needs of each segment of the cattle industry cow-calf, stocker, feedyard and dairy operations. The program covers best management practices such as proper handling and administration of vaccinations and other products, eliminating injection site blemishes, and better cattle-handling principles.
"One of the challenges that beef producers face is having all of their employees become BQA certified," says Dr. Jerry Woodruff, Professional Services Veterinarian with Boehringer Ingelheim Vetmedica, Inc. "Boehringer Ingelheim Vetmedica, Inc.'s partnership with BQA helps offset some of those expenses, and we encourage producers and their employees to use the web-based training programs."
More than 11,000 producers have taken advantage of Boehringer Ingelheim Vetmedica, Inc.'s BQA certification sponsorship. Boehringer Ingelheim Vetmedica, Inc.'s sponsorship also includes financial support of the Beef Cattle Institute at Kansas State University, which developed the certification module.
"We are honored to be able to support the cattle industry through this sponsorship," says Steve Boren, Executive Director of the U.S. Cattle and Equine Business Segments for Boehringer Ingelheim Vetmedica, Inc. "BQA education aligns with Prevention Works, our focus of preventing disease in cattle. We do this because it is the right thing for the animal, for the producer and for the consumer."
To become BQA certified, or learn more about the program, visit www.BIVI-BQA.com
ABOUT BOEHRINGER INGELHEIM
Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for the employees and their families and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors of all Boehringer Ingelheim's endeavors. With nearly 3,000 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about $1.46 billion (1.07 billion euros) in 2013. In our research-driven Animal Health business, Boehringer Ingelheim continually invests more than 10% of net sales of the Animal Health business in R&D For more information please visit www.bi-vetmedica.com
8.29.2014